Systematic review 2024

Safety of repeated low-level red-light therapy for myopia: A systematic review

Yanping Chen; Ruilin Xiong; Shaopeng Yang; Ziyu Zhu; Huangdong Li; Kaidi Xiang; Nathan Congdon; Wei Wang; Mingguang He

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

What does this source bring?

The RLRL safety review included 20 testing; 1436 participants received therapy. No permanent vision loss was reported in the analyzed corpus.

Median follow-up 9 months, maximum 24. Two descriptions referred to the same patient. The absence of an observed event does not prove zero risk.

CLAIM-RLRL-SAFETY

Scope of testing and verification

The role of the record
Source of the claim
Population
Children 3–18 years old; 20 research
N
2380
Geography
Globally
Observation (months)
24
Comparator
Varied research
Result
The RLRL safety review included 20 testing; 1436 participants received therapy. No permanent vision loss was reported in the analyzed corpus.
Safety
Afterimages, a description of reversible visual impairment and abnormalities OCT.
Device/structure
Not applicable / not determined within the verified range
Publisher of the publication
Elsevier BV
Financing
Not determined within the proven range; see the declaration in full text.
Conflicts of interest
Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
DOI
10.1016/j.apjo.2024.100124
PMID
39672511
What was checked
Bibliographic metadata and abstract in Europe PMC / PubMed; Crossref metadata
Date of verification
2026-09-09

This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.

Availability

Text size
100%
Contrast
Reading
SOURCE RECORD

Source record